TNF-α expression, as demonstrated using mouse models, is associated with development of colon cancer, while the inhibition of TNF-α reduces inflammation and tumor growth; the effect is particularly especially visible in mice, having received the anti-TNF agents, infliximab and etanercept (94,95). This evidence concerns the gene TNF and colonic neoplasm.